Similar articles for PMID: 22514846

Year	Number of Results
1925	1
1930	1
1997	1
1998	1
2002	2
2003	1
2004	6
2005	2
2006	2
2007	3
2008	4
2009	1
2010	3
2011	1
2012	2
2013	1
2015	13
2016	5
2017	6
2018	2
2019	2
2020	1
2021	1
2024	0

1

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction.

Center for Substance Abuse Treatment. Center for Substance Abuse Treatment. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004. Report No.: (SMA) 04-3939. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004. Report No.: (SMA) 04-3939. PMID: 22514846 Free Books & Documents. Review.

2

Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.

Kraus ML, Alford DP, Kotz MM, Levounis P, Mandell TW, Meyer M, Salsitz EA, Wetterau N, Wyatt SA; American Society Of Addiction Medicine. Kraus ML, et al. J Addict Med. 2011 Dec;5(4):254-63. doi: 10.1097/ADM.0b013e3182312983. J Addict Med. 2011. PMID: 22042215

3

Buprenorphine for office-based treatment of patients with opioid addiction.

Manlandro JJ Jr. Manlandro JJ Jr. J Am Osteopath Assoc. 2005 Jun;105(6 Suppl 3):S8-13. J Am Osteopath Assoc. 2005. PMID: 16118361 Review.

4

Geographic and specialty distribution of US physicians trained to treat opioid use disorder.

Rosenblatt RA, Andrilla CH, Catlin M, Larson EH. Rosenblatt RA, et al. Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735. Ann Fam Med. 2015. PMID: 25583888 Free PMC article.

5

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR. Fiellin DA, et al. J Subst Abuse Treat. 2004 Sep;27(2):153-9. doi: 10.1016/j.jsat.2004.06.005. J Subst Abuse Treat. 2004. PMID: 15450648 Review.

6

Using buprenorphine for outpatient opioid detoxification.

Manlandro JJ Jr. Manlandro JJ Jr. J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES11-6. J Am Osteopath Assoc. 2007. PMID: 17908825 Review.

7

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626

8

Bupreorphine:a new pharmacotherapy for opioid addictions treatment.

Stock C, Shum JH. Stock C, et al. J Pain Palliat Care Pharmacother. 2004;18(3):35-54. J Pain Palliat Care Pharmacother. 2004. PMID: 15364630 Review.

9

Managing opioid addiction with buprenorphine.

Donaher PA, Welsh C. Donaher PA, et al. Am Fam Physician. 2006 May 1;73(9):1573-8. Am Fam Physician. 2006. PMID: 16719249 Free article. Review.

10

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR. Raisch DW, et al. Ann Pharmacother. 2002 Feb;36(2):312-21. doi: 10.1345/aph.10421. Ann Pharmacother. 2002. PMID: 11847954 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year